'Golden age' of antibiotics 'set to end'

 
Lab research into new antibiotics Far fewer pharmaceutical companies are working on new antibiotics than in the past

Related Stories

We cannot say we weren't warned. The growing threat of antibiotic resistant organisms is once again in the spotlight.

Prof Jeremy Farrar, the new head of Britain's biggest medical research charity the Wellcome Trust said it was a "truly global issue".

In his first major interview since taking up his post, Prof Farrar told BBC Radio 4's Today programme that the golden age of antibiotics could come to an end unless action is taken.

His comments echo those of England's Chief Medical Officer Dame Sally Davies.

Last year she described the growing resistance to antibiotics as a "ticking time bomb", and said the danger should be ranked alongside terrorism on a list of threats to the nation.

Previous chief medical officers have also warned about the threat from pathogens - bacteria, viruses and parasites.

And G8 science ministers in London discussed the danger from drug resistant infectious agents when they met in June 2013.

'Older than humanity'

But the warnings actually started many years ago.

In 1998 a House of Lords report gave this stark assessment: "Antibiotic resistance threatens mankind with the prospect of a return to the pre-antibiotic era."

Most of us were born into a world containing antibiotics, so it is easy to feel they are permanent fixtures in the arsenal of medicines.

In fact penicillin did not go into widespread use until the 1950s.

You can visit Sir Alexander Fleming's tiny laboratory at St Mary's hospital in London where he made the discovery in 1928.

But whereas antibiotics have been around for less than a century, infectious agents are older than humanity, and are continually evolving.

Two bacterial infections illustrate the problem.

Multi-drug resistant (MDR) tuberculosis is rising steadily worldwide.

TB- X-ray The incidence of different forms of drug resistant TB is on the rise

Doctors in London have reported a sharp rise in cases of MDR TB, which can take two years to treat successfully.

That is bad enough, but there are now strains which are even worse.

Five years ago, I reported from South Africa on the growing threat of Extremely Drug Resistant (XDR) TB, which, as the name sounds, is virtually untreatable.

Again this illustrates that these public health threats don't spring up overnight; the warning signs emerge over a long period.

Another example is the rise in infections from enterobacteriaceae - bugs that live in the gut like E.coli and Klebsiella.

They are now the commonest cause of hospital acquired infection and some are becoming resistant to carbapenems, a powerful, last resort group of antibiotics.

There has also been an alarming increase in rates of the sexually transmitted disease gonorrhoea, which is becoming more difficult to treat.

Prof Farrar said we could have used our antibiotics better and we should have invested more in research on infectious diseases.

He said there are just four pharmaceutical companies working on antibiotics now compared to 18 companies 20 years ago.

And Prof Farrar called for industry to be given incentives to work on antibiotics and greater restrictions placed on access to these medicines.

The World Health Assembly of the WHO will discuss the issue in May.

 
Fergus Walsh, Medical correspondent Article written by Fergus Walsh Fergus Walsh Medical correspondent

Analysis: Assisted dying debate

Reflections on one of the most significant issues facing society

Read full article

More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites

Comments

This entry is now closed for comments

Jump to comments pagination
 
  • rate this
    +1

    Comment number 140.

    A pox on you all....

  • rate this
    +1

    Comment number 139.

    It is inevitable that some of the organisms will evolve by natural selection and survive the current drugs. We continue to find new ones which combats this to some extent. For some periods we will be ahead, for some losing ground. Maybe eventually a new type of drug will be found but it too will have a limited Long term effect

  • rate this
    0

    Comment number 138.

    Unfortunately we hve too many 'ambulance chasing' lawyers who by their great knowledge of medicine are able to jump down the throats and wallets of anyone who has not prescribed antibiosis for a simple nick with a razor or a moggy with a head cold.

  • rate this
    +2

    Comment number 137.

    Regulate the use of ABs in the food industry - it’s use is too wide spread.

    Force all drug companies to publish all information on drug trials, toxicity, after affects, and long term exposure problems etc.

    Break up the huge monopolies formed by multinational pharmaceutical companies. Keep the number of companies high, allow reasonably large companies & more & better research will result.

  • rate this
    +2

    Comment number 136.

    130. Amie
    Maybe to slow the amount of antibiotics down, would it be such a bad idea for the responsibility of prescribing antibiotics to be taken away from GPs and used only by hospital consultants for seriously ill inpatients only?
    --
    It would be insanity. People who's pneumonia could be cured at home with pennies worth of antibiotics would instead need £1000s of NHS care in hospital.

 

Comments 5 of 140

 

Features & Analysis

  • Dr Mahinder Watsa Dr Sex

    The wisecracking 90-year-old whose advice column is a cult hit


  • Payton McKinnonKilling heat

    Why so many American children die in hot cars


  • Satellite image of debris fieldForensic challenges

    Contamination and tampering could hamper MH17 investigation


  • A tunnel dug by HamasGaza's underworld

    How Hamas spawned network of 'Viet Cong' tunnels


BBC Future

(Getty Images)

How to learn while you sleep

Enhance memory with your eyes shut Read more...

Programmes

  • (File photo) Usain BoltClick Watch

    Challenging the world's fastest man to a virtual race over 40m – can you keep up?

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.